AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0

Glyoka-VM2 Tablet SR

Prescription Icon
Prescription Required

Marketer

Ayati Pharma Pvt Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)

Overview Glyoka-VM2 Tablet SR

Diabexe-Duo SR tablets are classified as antidiabetic medications, a combination therapy for adult type 2 diabetes mellitus. This medication helps manage blood glucose levels. Diabexe-Duo SR should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan, including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are essential. Alcohol consumption should be minimized due to increased hypoglycemia risk. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain may occur. Diabexe-Duo SR is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring and periodic blood tests (blood cell counts, liver function) are recommended.

Primary Ingredients of Glyoka-VM2 Tablet SR

No text provided. Please provide the text you wish me to rephrase.

Uses of Glyoka-VM2 Tablet SR

Managing type 2 diabetes

Major Benefits of Glyoka-VM2 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for Glyoka-VM2 Tablet SR. Ingest the tablet whole; do not chew, crush, or break it. Administer on an empty stomach.

Common Side effects of Glyoka-VM2 Tablet SR:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Glyoka-VM2 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for Glyoka-VM2 Tablet SR. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.

How Glyoka-VM2 Tablet SR works:

The extended-release Glyoka-VM2 tablet contains a triple combination of antidiabetic agents.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol concurrently with Glyoka-VM2 Tablet SR is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glyoka-VM2 Tablet SR during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescription. Consult your doctor for advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The extended-release Glyoka-VM2 tablet is likely unsuitable for breastfeeding mothers. Available human data indicate potential transfer of the medication into breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyUNSAFE

The use of Glyoka-VM2 Tablet SR is contraindicated in patients with kidney impairment and should be avoided. Individuals with severe renal dysfunction should especially refrain from using this medication. Consult a physician before taking this medicine.

LiverLiverCAUTION

Exercise caution when prescribing Glyoka-VM2 Tablet SR to individuals with hepatic impairment. Dosage modification may be necessary. Physician consultation is advised. For patients exhibiting mild to moderate liver dysfunction, initiate Glyoka-VM2 Tablet SR therapy at a reduced dosage; its use is contraindicated in those with severe liver disease.

What if you forget to take Glyoka-VM2 Tablet SR :

Should you forget a Glyoka-VM2 Tablet SR dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glyoka-VM2 Tablet SR

LabelValue
Potential for Dependence None.
Medication Classification Medication for diabetes

FAQs on Glyoka-VM2 Tablet SR

Glyoka-VM2 SR tablets contain glimepiride, metformin, and voglibose, a triple-drug formulation for managing type 2 diabetes mellitus in adults. The medication enhances blood glucose control when coupled with dietary adjustments and regular physical activity. Glimepiride stimulates insulin secretion from the pancreas to reduce blood glucose. Metformin reduces hepatic glucose production and increases insulin sensitivity. Voglibose, an alpha-glucosidase inhibitor, decreases postprandial blood sugar. This combination therapy is unsuitable for type 1 diabetes.
Glyoka-VM2 SR tablets may cause common adverse reactions including low blood glucose, nausea, diarrhea, taste disturbances, gas, abdominal pain, headache, skin eruptions, and respiratory infections.
Patients with hypersensitivity to Glyoka-VM2 Tablet SR constituents or inactive ingredients should not use this medication. Its administration is contraindicated in individuals with moderate to severe renal impairment, inflammatory bowel conditions, colonic ulcers, and underlying metabolic acidosis, such as diabetic ketoacidosis.
Combining Glyoka-VM2 Tablet SR and alcohol is unsafe. This combination may dangerously reduce blood sugar (inducing hypoglycemia) and heighten the risk of lactic acidosis.
Indeed, Glyoka-VM2 Tablet SR can induce hypoglycemia, characterized by low blood glucose. Manifestations of low blood sugar may include nausea, headache, irritability, increased hunger, sweating, lightheadedness, tachycardia, and feelings of anxiety or tremor. The risk of hypoglycemia increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. Carrying glucose tablets, honey, or fruit juice is strongly recommended.
Retain this medication within its original, sealed packaging. Store as directed on the product packaging or label. Discard any leftover medication. Prevent access by children, pets, and others.
Glyoka-VM2 Tablet SR
98
MRP 120
18% off